The Government Urged to Erase Social Media Claims About the Vaccine Program Denunciation

Unexpectedly, The Thai court directed a leading government enemy to delete social media claims that the coronavirus vaccine program of the state is vague and disproportionately benefits a king-owned company. Nevertheless, the Democratic Campaign of opposition politician Thanathorn Juangroongruangkit denied the videos were illegal and urged YouTube and Facebook to protect democracy.

The Criminal Court ruled that Mr Thanathorn’s posts on social media and his movement’s website might violate national security. The videos accuse the government of Prime Minister Prayut Chan-o-cha of avoiding accountability in enabling, despite a lack of vaccine expertise, Siam Bioscience, which is owned by King Maha Vajiralongkorn, to supply most doses.

In a 2019 referendum to retain power a claim he rejects opponents argue former junta leader Prayuth rigged a vote and violated a national silence by increasingly criticising the monarchy. A 600 million baht (S$13.4 million) subsidy was obtained by Siam Bioscience to build the capacity to produce AstraZeneca vaccines domestically and throughout Southeast Asia.

When approached by Reuters, the court did not comment. The Campaign of Mr. Thanathorn said it had not earned the ruling. The government has also filed a video complaint against him, accusing him of offending monarchy, an accusation punishable by up to 15 years in jail.

The government says the development of Siam Bioscience is on schedule to provide to the public a first batch of 61 million doses by June. There was no immediate comment on the court decision from Mr Thanathorn or Siam Bioscience. Traditionally, the palace does not elaborate on political conflicts.

Relatively unscathed by Covid-19, Thailand confirmed 829 new cases of coronavirus recently, taking the total since the epidemic began last January to 18,782 cases and 77 fatalities.

Looking back the delivering 50,000 doses of AstraZeneca vaccine to high-risk groups next month, will launch its coronavirus inoculation campaign, as it faces charges of being too late to procure vaccines.

The food and drug administration of Thailand approved the AstraZeneca vaccine for emergency use, but has yet to give authorisation to Sinovac Biotech, of which two million doses have been requested by Thailand. However, Health Minister Anutin Charnvirakul said AstraZeneca will provide 50,000 fewer doses of the vaccine than the 200,000 requested by Thailand. Through this, it’s a mystery to think about the things happening in inoculation of the vaccine throughout the nation.

Burapha

Sawadee-khrup. I am a multicultural Thai newswriter that is always on the lookout for daily news that are intriguing and unique in my native country Thailand.

Recent Posts

BAFTA 2026 nominations announced with surprise snubs in major categories

The BAFTA 2026 nominations have officially been unveiled, setting the stage for a dramatic awards season. Paul Thomas Anderson has…

January 28, 2026

Mobile Legends M7 World Championship breaks all-time viewership records

The M7 World Championship has officially rewritten esports history, establishing itself as the most-watched mobile esports event of all time.…

January 28, 2026

Netflix Unveils Riveting ASEAN Crime Drama Filmed in Malaysia and the Philippines

Netflix continues to solidify its commitment to Southeast Asian storytelling with the announcement of a high-octane ASEAN crime drama. This…

January 28, 2026

Popular Food Trends 2026: Fusion Street Food from Thailand and Malaysia Tops Regional Charts

Fusion street food from Thailand and Malaysia dominates 2026 culinary rankings, blending bold regional flavors with global twists. Thai-Malay fusion…

January 28, 2026

“63rd ASEAN National Tourism Organizations Meeting” Kicks Off in Cebu, Focusing on Future‑Ready Tourism in Southeast Asia

On January 26, 2026, at the Nustar Hotel in Cebu City, Philippines, the 63 rd ASEAN National Tourism Organizations Meeting…

January 28, 2026

New “Clawdbot” AI Agent Raises Security Concerns for Enterprise Users

Clawdbot, the viral open-source AI agent, promises powerful automation but sparks major security concerns for businesses. This local-first assistant was…

January 28, 2026

This website uses cookies.

Read More